Accord Pharmaceuticals limited (ACPL) IPO
SEBON has approved an issue of 7,06,909 units (Rs 7,06,90,900) for the general public; no opening date has been announced yet. Issue manager: Global IME Capital Ltd.
How to check your IPO result
Opens the official site in a new tab. Your BOID stays between you and CDSC; NepsezAI never asks for it.
| Tranche | Status | Units | Price | Opens | Closes | Last date | Listed | Issue manager |
|---|---|---|---|---|---|---|---|---|
| general public | Pipeline | 7,06,909 | — | — | — | — | — | Global IME Capital Ltd |
ACPL IPO FAQs
- How many units does the Accord Pharmaceuticals limited IPO offer, and at what price?
- 7,06,909 units at Rs 100 per share for the general public.
- Who is the issue manager for the ACPL IPO?
- Global IME Capital Ltd.
- How do I check the Accord Pharmaceuticals limited IPO result?
- On iporesult.cdsc.com.np choose Accord Pharmaceuticals limited and enter your BOID, or in MeroShare open My ASBA → Application Report.
- What is the minimum application for the ACPL IPO?
- Normally 10 units. When an issue is oversubscribed, allotment is a lottery over applications, so applying for more units does not raise your chance.